Sign in with your email address username.


[Correspondence] China’s medical research integrity

As Chinese medical scholars, we think that the title of The Lancet Editorial “China’s medical research integrity questioned” (April 11, p 1365)1 is overgeneralised. 42 retracted manuscripts is insufficient to question the research integrity of the whole country, especially considering the overwhelming number of medical publications from China. Because of the high influence and prestige of The Lancet, we worry that this Editorial might exacerbate the trust crisis in medical research and further prejudice the outcome of manuscripts submitted by Chinese researchers to international journals (the acceptance rate is already low).